Tevogen Bio Holdings Inc (TVGN) - News Archive

Tevogen Bio Expands HLA Coverage for Precision T Cell Therapy in Major Clinical Milestone In a significant advancement in the field of precision medicine, Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has announced a major c...

In an exciting development for both the biotechnology and artificial intelligence sectors, Tevogen Bio Holdings Inc. (Nasdaq: TVGN) recently announced that Mittul Mehta, the company’s Chief Information Officer and Head...

The Revolution in Precision Immunotherapy: Tevogen Bio s Groundbreaking Advances in Allogeneic T Cell TherapyIn the ever-evolving landscape of biotechnology, companies are racing to develop innovative therapeutic approa...

News Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2 WARREN, N.J., Sept. 03, 2025 Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has take...

WARREN, N.J., July 18, 2025 Tevogen Bio Holdings Inc. (Nasdaq: TVGN), a biotech company specializing in innovative immunotherapy solutions, has made significant strides in artificial intelligence as it merges cutting-ed...

Tevogen Bio Paves the Way in Biopharma Innovation with New Facility and AI Initiatives Warren, N.J. In a significant move to bolster its production capabilities, Tevogen Bio Holdings Inc. has announced the signing of a...

In the burgeoning landscape of biopharmaceutical innovation, Tevogen Bio Holdings Inc. (Nasdaq: TVGN) is making decisive strides toward becoming a transformative force within the industry. The company recently celebrate...

Tevogen Bio Holdings Inc. Responds to Rising Shareholder Interest in Direct Registration System (DRS) A New Chapter for Tevogen Bio Holdings Inc.Tevogen Bio Holdings Inc. (NASDAQ: TVGN), a burgeoning biotechnology compa...

Tevogen Bio Projects $1 Billion in Oncology Revenue in Launch Year, Up to $14 Billion Over Five Years Tevogen Bio Holdings Inc. a biotech company based in Warren, New Jersey, has reaffirmed its ambitious revenue project...

April 15, 2025 Warren, N.J. In a significant advancement toward the future of precision medicine, Tevogen Bio Holdings Inc. has announced its collaboration with Databricks, Inc. a recognized leader in data, analytics, a...

Warren, N.J. April 9, 2025 In a significant move to enhance pharmaceutical manufacturing within the United States, Tevogen Bio Holdings Inc. (Nasdaq: ), a key player in innovative healthcare solutions, has announced the...

In a climate where biotechnology firms are under increasing pressure to demonstrate financial viability, Dr. Ryan Saadi, the CEO and founder of Tevogen Bio Holdings Inc. (Nasdaq: TVGN), has taken a clear stance focused...

Warren, N.J. Tevogen Bio Holdings Inc. a forefront player in the field of immunotherapy, has taken significant strides in its pursuit of transformative medical solutions by broadening its partnership with Microsoft. Thi...

Celebrating Public Service and Corporate Milestones: The Hall of Fame Induction of Victor SordilloIn an age where global crises demand local leadership, the importance of individuals who dedicate their lives to public s...

Tevogen Bio Charts Ambitious Growth Path with Strategic Organizational Changes and New InvestmentIn a notable move that underscores its commitment to advancing immunotherapy solutions, Tevogen Bio Holdings Inc. (Nasdaq:...

Tevogen Bio Receives $6 Million Investment as It Advances Innovative Immunotherapy SolutionsIn an exciting development for the biotechnology sector, Tevogen Bio Holdings Inc. a clinical-stage immunotherapy company, anno...

Tevogen Bio Holdings Inc. (Nasdaq: TVGN), a prominent clinical-stage biotech company specializing in immunotherapy, has recently reported its financial results for the third quarter of 2024, ending September 30. This an...

for CSIMarket.com Tevogen Bio’s Strategic Expansion: Revolutionizing Immunotherapy with Off-the-Shelf T Cell Therapeutics The field of immunotherapy is witnessing significant advancements with the innovative work of Tev...

Leveraging Artificial Intelligence to Enhance HPV Target Identification: Tevogen Bio and Microsoft Partnership Tevogen Bio Holdings Inc. a clinical-stage biotechnology firm, has recently announced a strategic partnershi...

Revolutionizing Patient Engagement through Community Advocacy Tevogen Bio, a dynamic clinical-stage immunotherapy biotech company, has made a pivotal appointment that underscores its commitment to patient-centric care....